Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Biofrontera股價上漲，公司宣佈Ameluz與BF-RhodoLED燈治療SBCC的3期研究取得頂線結果。
Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Biofrontera股價上漲，公司宣佈Ameluz與BF-RhodoLED燈治療SBCC的3期研究取得頂線結果。